Brief: United Therapeutics Q2 Revenue USD 714.9 Million Vs. IBES Estimate USD 691.9 Million
31/07/2024 11:30
Jul 31 (Reuters) - United Therapeutics Q2 net income USD 278.1 million
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug